IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook
1. IDXX shares rose over 10% after strong Q2 results. 2. Q2 GAAP EPS was $3.63, exceeding analysts' expectations. 3. Revenue grew 11% YoY to $1.11 billion. 4. Company raised EPS forecast to $12.40–$12.76. 5. IDXX emphasizes strong customer loyalty for long-term growth.